CIK 0001882782 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Odyssey Therapeutics, Inc.
Sign in to watch- Ticker
- ODTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863384382
- Phone
- (212) 841-1000
- Business address
- 51 SLEEPER STREET, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Sale | −277 | $18.00 | $5K | 440,981 |
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +133,333 | $18.00 | $2.4M | 574,314 |
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Conversion | +463,106 | 463,106 | ||
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Conversion | +273,527 | 736,633 | ||
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Option exercise | +78,656 | 815,289 | ||
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Sale | −438 | $18.00 | $8K | 814,851 |
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +200,000 | $18.00 | $3.6M | 1,014,851 |
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Conversion · Series A Convertible Preferred Stock | −4,606,320 | 0 | ||
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Conversion · Series A-2 Convertible Preferred Stock | −1,299,842 | 0 | ||
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Conversion · Series B Convertible Preferred Stock | −544,162 | 0 | ||
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Conversion · Series C Convertible Preferred Stock | −600,142 | 0 | ||
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Conversion · Series D Convertible Preferred Stock | −6,644,650 | 0 | ||
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Option exercise · Series D Warrants (Right to Buy) | −1,861,211 | 0 | ||
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Conversion · Series A Convertible Preferred Stock | −1,151,580 | 0 | ||
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Conversion · Series B Convertible Preferred Stock | −2,374,981 | 0 | ||
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Conversion · Series B Convertible Preferred Stock | −1,899,984 | 0 | ||
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Conversion · Series C Convertible Preferred Stock | −200,000 | 0 | ||
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Conversion · Series D Convertible Preferred Stock | −1,614,650 | 0 | ||
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Option exercise · Series D Warrants (Right to Buy) | −484,395 | 0 | ||
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Conversion · Series C Convertible Preferred Stock | −4,500,000 | 0 |
Page 2 of 4 · 79 trades